Solvonis Therapeutics plc (LON:SVNS)
London · Delayed Price · Currency is GBP · Price in GBX 0.3462
-0.0338 (-8.89%)
Sep 30, 2025, 3:37 PM BST
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 24.34 million as of September 30, 2025. Its market cap has increased by 670.85% in one year.
Market Cap
24.34M
Enterprise Value
23.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has increased from 23.03M to 24.34M, an increase of 5.66%. That is a compound annual growth rate of 1.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 24.34M | 417.04% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
| Jan 6, 2022 | 23.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rolls-Royce Holdings | 99.25B |
| RELX PLC | 63.59B |
| BAE Systems | 60.01B |
| Experian | 33.71B |
| Ashtead Group | 21.15B |
| International Consolidated Airlines Group | 17.72B |
| Halma | 12.66B |
| Rentokil Initial | 9.29B |